Super Spectra Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Super Spectra Ltd. - overview
Location
-, -, Israel
Primary Industry
Medical Devices & Equipment
About
Based in Israel, and founded in 2014 by Evgeny Beiderman, Super Spectra Ltd. , a. k. a.
Super Spectra operates as a medical device company that focuses on developing non-invasive imaging devices for the early detection and monitoring of Alzheimer’s disease (AD). Super Spectra raised venture funding from Peregrine Ventures. Super-Spectra offers a non-invasive imaging device for early detection and monitoring of Alzheimer's disease. This device measures cerebrospinal fluid (CSF) biomarkers, specifically Aβ and τ proteins, providing quantitative results.
It combines two electro-optic technologies: focusing and imaging behind a highly scattering medium, and super-resolved Raman spectroscopy.
Current Investors
Peregrine Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Monitoring Equipment, Diagnostic Equipment
Verticals
HealthTech, Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.